1995
DOI: 10.1161/01.cir.92.3.286
|View full text |Cite
|
Sign up to set email alerts
|

Elevation of Circulating and Ventricular Adrenomedullin in Human Congestive Heart Failure

Abstract: The present study demonstrates that plasma concentration of ADM is increased in patients with CHF and that ADM is present in the human heart. ADM immunoreactivity is markedly increased in the failing human ventricle, suggesting that ventricular ADM expression may be influenced by the circumstances associated with CHF. This supports a potential role for this newly identified vasoactive and natriuretic peptide, ADM, in the neurohumoral activation that characterizes human CHF.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

13
184
2
3

Year Published

1996
1996
2019
2019

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 354 publications
(202 citation statements)
references
References 15 publications
13
184
2
3
Order By: Relevance
“…Elevated circulating levels of cardiac troponin 1, a specific marker of myocardial injury [31], have also been reported in cirrhosis without other causes of cardiac disease [32]. Similar elevated levels of adrenomedullin, a hormone involved in the regulation of vascular tone and natriuresis [33] as well as influencing myocardial inotropy [34,35], have been found in cirrhosis without clinical heart disease [36,37] as in patients with heart failure [38,39] and ventricular hypertrophy [40]. Adrenomedullin mediates its effects through its second messenger, cyclic adenosine mono-phosphate (cAMP), which, in turn, increases the production of nitric oxide (NO) [41].…”
Section: Serum Markersmentioning
confidence: 89%
“…Elevated circulating levels of cardiac troponin 1, a specific marker of myocardial injury [31], have also been reported in cirrhosis without other causes of cardiac disease [32]. Similar elevated levels of adrenomedullin, a hormone involved in the regulation of vascular tone and natriuresis [33] as well as influencing myocardial inotropy [34,35], have been found in cirrhosis without clinical heart disease [36,37] as in patients with heart failure [38,39] and ventricular hypertrophy [40]. Adrenomedullin mediates its effects through its second messenger, cyclic adenosine mono-phosphate (cAMP), which, in turn, increases the production of nitric oxide (NO) [41].…”
Section: Serum Markersmentioning
confidence: 89%
“…ADM is an adipokine (3) and is expressed in many different tissues, including adipose tissue, adrenal medulla, lung, heart, and kidney (1)(2)(3)(4). Its plasma level is elevated in obesity (5-7), hypertension (8,9), renal failure (8,9), type 2 diabetes (10)(11)(12), and congestive heart failure (8,13). ADM also plays an important regulatory role in both acute and chronic inflammation (14)(15)(16).…”
Section: Introductionmentioning
confidence: 99%
“…Cardiomyopathy induced by catecholamines Journal of Human Hypertension has been observed in animals as well as in humans after infusion of vasopressor drugs or in association with pheochromocytoma. 4 In congestive heart failure elevation of circulating and ventricular adrenomedullin has been documented, 5 as well as a myocardial stunning-like phenomenon during a crisis of pheochromocytoma. 6 Bradydysrhythmias, for instance sinus node arrest, without systemic hypertension 7 and ventricular arrhythmias, associated with intermittent hypertension 8 can be secondary to pheochromocytoma and disappear after removal of the tumour.…”
Section: Discussionmentioning
confidence: 99%